Neural Stem Cell ApS: Financial statements 2025
CVR: 43710273
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Neural Stem Cell ApS (CVR 43710273) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -12,278 and a net result of DKK -51,093 compared with DKK -1,334 the year before. Equity in the 2025 report amounted to DKK -12,427.
- Gross Profit
- DKK -12,278
- Profit/Loss
- DKK -51,093
- Equity
- DKK -12,427
- Total Assets
- DKK 34,208
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -12K | -51K | -12K | 0 |
| 2024 | - | -1 | -1K | 39K | 0 |
| 2023 | - | 0 | 0 | 40K | 0 |
Official annual report
How creditworthy is Neural Stem Cell ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Neural Stem Cell ApS has published its annual report for 2024. Gross profit came to DKK -1, and the net result was DKK -1,334.
About Neural Stem Cell ApS
Neural Stem Cell ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2022. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Brian Taammoli. The company is owned by Brian Taammoli. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -12,278 and a net result of DKK -51,093 compared with DKK -1,334 the year before. Equity in the 2025 report amounted to DKK -12,427.